Rapid and severe Covid-19 pneumonia with severe acute chest syndrome in a sickle cell patient successfully treated with tocilizumab

Am J Hematol. 2020 Jul;95(7):876-878. doi: 10.1002/ajh.25833. Epub 2020 May 12.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Acute Chest Syndrome / diagnostic imaging
  • Acute Chest Syndrome / etiology*
  • Acute Chest Syndrome / therapy
  • Anemia, Sickle Cell / complications*
  • Anemia, Sickle Cell / drug therapy
  • Antibodies, Monoclonal, Humanized / therapeutic use*
  • Betacoronavirus*
  • COVID-19
  • Combined Modality Therapy
  • Coronavirus Infections / complications*
  • Coronavirus Infections / drug therapy
  • Coronavirus Infections / therapy
  • Drug Therapy, Combination
  • Humans
  • Hydroxychloroquine / therapeutic use
  • Male
  • Middle Aged
  • Oxygen Inhalation Therapy
  • Pandemics
  • Pneumonia, Viral / complications*
  • Pneumonia, Viral / drug therapy
  • Pneumonia, Viral / therapy
  • SARS-CoV-2
  • Tomography, X-Ray Computed

Substances

  • Antibodies, Monoclonal, Humanized
  • Hydroxychloroquine
  • tocilizumab

Supplementary concepts

  • COVID-19 drug treatment